Stamin Millennium Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 15 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.80 Cr
- Satisfied Charges ₹ 7.87 M
- Revenue Growth 730.84%
- Profit Growth -106.37%
- Ebitda -188.53%
- Net Worth -366.54%
- Total Assets 20.94%
About Stamin Millennium Nutraceuticals
Stamin Millennium Nutraceuticals Private Limited (SMNPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 February 2009 and has a history of 15 years and 11 months. Its registered office is in Kanchipuram, Tamil Nadu, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹2.80 Cr. The company has closed loans amounting to ₹7.87 M, as per Ministry of Corporate Affairs (MCA) records.
Daniel Muniappan and Arun Thomas serve as directors at the Company.
Company Details
-
Location
Kanchipuram, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U24293TN2009PTC070818
-
Company No.
070818
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Feb 2009
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Stamin Millennium Nutraceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daniel Muniappan
|
Director | 17-Mar-2021 | Current |
|
Arun Thomas
|
Additional Director | 12-Aug-2024 | Current |
Financial Performance of Stamin Millennium Nutraceuticals.
Stamin Millennium Nutraceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 730.84% increase. The company also saw a substantial fall in profitability, with a 106.37% decrease in profit. The company's net worth observed a substantial decline by a decrease of 366.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Stamin Millennium Nutraceuticals?
Unlock access to Stamin Millennium Nutraceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Dr.Ethix's Products And Services LimitedDaniel Muniappan and Arun Thomas are mutual person
Charges (Loans)
₹27.96 M
₹7.87 M
Charges Breakdown by Lending Institutions
- Others : 2.80 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 May 2022 | Others | ₹1.90 Cr | Open |
| 03 Jan 2012 | Others | ₹9.00 M | Open |
| 24 Jul 2010 | Indian Bank | ₹6.00 M | Satisfied |
| 05 May 2009 | Corporation Bank | ₹1.87 M | Satisfied |
How Many Employees Work at Stamin Millennium Nutraceuticals?
Stamin Millennium Nutraceuticals has a workforce of 13 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Stamin Millennium Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Stamin Millennium Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
